Researchers evaluated the incidence and risk factors for ketoacidosis among adults with type 2 diabetes receiving treatment with SGLT2 inhibitors.

New York Gov. Kathy Hochul has declared a statewide emergency as measles spreads through rural parts of the state.

While lower-frequency IET may be sufficient to maintain BP reductions over the short term, higher frequencies are required to preserve the full CV benefits.

The prevalence of neurodiversity is increased among individuals diagnosed with type 2 diabetes (T2D) early in life.

For adults aged 60 to 69 years, lower cognitive functioning in global cognition and perceptual speed is associated with increased stroke risk.

Compared with standard care alone, a hybrid lifestyle intervention did not significantly improve weight loss in adults with obesity.

Continuous glucose monitoring threshold alerts improve time in range and reduce time above range for hospitalized adults with diabetes.

The FDA granted Priority Review to the NDA for infigratinib, an oral FGFR3 inhibitor for pediatric achondroplasia, with a PDUFA action date of February 4, 2027.

Eliminating television commercials for unhealthy foods and beverages is projected to decrease obesity rates among children and adolescents.

PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.

Therapy with GLP-1 RAs reduces the frequency of apnea and hypopnea events in obesity, serving as an effective adjunct to ...

Tirzepatide therapy reduces the risk for major adverse cardiovascular events in patients with type 2 diabetes and established CVD.